106.213 articles found

Effects of Focal Muscle Vibration on Static and Dynamic Balance in Patients with Parkinson's Disease: Preliminary Results of a Retrospective Study.

Ferrara PE, Della Casa E, Calciano R, Ricciardi D, Tassi L, Cutaia A, Lama E, Lombardo C, Fusco A, Ferriero G, Ronconi G.

Medicina (Kaunas) · 2026-02-02

DOI: 10.3390/medicina62020300PMID: 41752699

Multi-omics dissection of Parkinson's patients in subgroups associated with motor and cognitive severity.

Athieniti E, Afxenti S, Minadakis G, Spyrou GM.

Neurobiol Dis · 2026-02-02

DOI: 10.1016/j.nbd.2026.107288PMID: 41638367

A neuropeptide receptor-enriched transcriptional state characterizes resilient dopaminergic neurons in Parkinson's disease.

Zheng Q, Lin X, Fei G, Xiao L.

Neurobiol Dis · 2026-02-02

DOI: 10.1016/j.nbd.2026.107303PMID: 41638368

Transcranial alternating current stimulation can disrupt or reestablish neural entrainment in parkinsonian motor cortex.

Tran H, Mohanty B, Hjelle N, Zhao Z, Lee S, DeNicola A, Alekseichuk I, Wischnewski M, Wang J, Vitek J, Johnson L, Opitz A.

Brain Stimul · 2026-02-02

DOI: 10.1016/j.brs.2026.103045PMID: 41638627

Identification of DARPP-32 as a novel sleep regulator in physiological conditions and experimental Parkinsonism.

Pisanò CA, Santino ML, Russotto A, Fisone G.

iScience · 2026-02-02

DOI: 10.1016/j.isci.2026.114882PMID: 41732273

Provision of pain care services for people with Parkinson's disease from the perspective of healthcare providers: A qualitative descriptive study.

Mezzini A, Kumar S, Sharrad S, Harmon J, Eckert M.

Int J Nurs Stud · 2026-02-02

DOI: 10.1016/j.ijnurstu.2026.105364PMID: 41691790

Analgesic Benefit of Low-Dose Foslevodopa/Foscarbidopa Infusion in Advanced Parkinson's Disease: A Non-Standard Therapeutic Application.

Kennelly L, Sweeney B, Olszewska DA.

Mov Disord Clin Pract · 2026-02-02

DOI: 10.1002/mdc3.70550PMID: 41626644

Mouth Motor Overflow in Parkinson's Disease.

Makhoul K, Jankovic J.

Mov Disord Clin Pract · 2026-02-02

DOI: 10.1002/mdc3.70548PMID: 41623012

An antioxidative injectable chitosan hydrogel based on tannic acid modified dialdehyde polyurethane nano-crosslinker targeting RIPK1 to regulate neuroinflammation for amelioration of Parkinson's disease

Xu J, Guo C, Zhou G, Chen H, Dai P, Tang C, Lin SH, Chen TY, Zhang C, Chen F, Dong N, Li C, Pan J, Chen X, Wu P, Li S, Luo LH, Li X, Shuai J, Hsu SH, Wang Z.

Biomaterials · 2026-02-01

Poster Session I - A30 INVESTIGATING THE IMPACT OF PARKINSON’S DISEASE-ASSOCIATED GENE PINK1 ON INTESTINAL HOMEOSTASIS AND RESPONSE TO INFECTION

Check source for author details

Journal of the Canadian Association of Gastroenterology · 2026-02-01

Motor recovery through perineuronal net modulation in a Parkinson's disease mouse model.

Benacom D, Chataing C, Prochiantz A, Di Nardo AA.

Brain · 2026-02-01

DOI: 10.1093/brain/awaf226PMID: 40501146

Bridging the Gaps: Imputation of Parkinson's Disease Clinical Assessments With Federated Learning.

Reyes J, Noroozi A, Xiao Y, Kersten-Oertel M.

IEEE J Biomed Health Inform · 2026-02-01

DOI: 10.1109/jbhi.2025.3593459PMID: 40729715